Human TAZ/WWTR1 PharmaGenie ELISA Kit (SBRS1133)

TAZ/WWTR1, the transcriptional coactivator that operates as a downstream effector of the Hippo signaling pathway, plays a central role in regulating cell proliferation, apoptosis, and organ size. Researchers studying Hippo pathway biology, oncology targets, and tissue fibrosis models need reliable quantification of TAZ protein levels, and the Assay Genie Human TAZ/WWTR1 PharmaGenie ELISA Kit delivers quantitative measurement for those investigations.

The kit is supplied as a 96-assay pack and is configured to measure endogenous TAZ/WWTR1 in cell culture supernatant, plasma, or serum samples. Detection relies on a colorimetric readout, and the format is intended for research use only. The assay supports studies that compare relative TAZ/WWTR1 expression across experimental conditions, including Hippo pathway perturbation, gene knock-down and overexpression models, and pharmacological compound screening.

Beyond pathway research, the kit supports translational work such as biomarker hypothesis testing in clinical research samples and characterization of disease models where WWTR1 dysregulation has been linked to tumor progression and fibrotic disease. Each kit contains the reagents needed to build a standard curve and run a full microplate of samples and controls.